Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 34 Carcinoma, Non-Small-Cell Lung 20 Squamous Cell Carcinoma of Head and Neck 19 Esophageal Neoplasms 19 Head and Neck Neoplasms 13 Nasopharyngeal Carcinoma 12 Uterine Cervical Neoplasms 11 Pancreatic Neoplasms 9 Oropharyngeal Neoplasms 8 Lung Neoplasms 7 Glioblastoma 6 Esophageal Squamous Cell Carcinoma 6 Carcinoma, Squamous Cell 6 Neoplasms 5 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4 Mouth Neoplasms 4 Hypopharyngeal Neoplasms 4 Colorectal Neoplasms 4 Carcinoma 4 Adenocarcinoma 4 Radiation Injuries 3 Pathologic Complete Response 3 Laryngeal Neoplasms 3 Breast Neoplasms 3 Thymoma 2 Resectable Esophageal Cancer 2 Neoplasms by Site 2 Nasopharyngeal Neoplasms 2 NSCLC 2

Interventions

Nivolumab 1 Ipilimumab 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Inoperable œsophageal Cancer × Chemoradiotherapy × Clear all

NCT03437200 2023-02-21

CRUCIAL

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Inoperable œsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡